0001832728-20-000001.txt : 20201117 0001832728-20-000001.hdr.sgml : 20201117 20201117171407 ACCESSION NUMBER: 0001832728-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201117 DATE AS OF CHANGE: 20201117 EFFECTIVENESS DATE: 20201117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Apertor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001832728 IRS NUMBER: 853493161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380841 FILM NUMBER: 201322004 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: (857) 352-3657 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 D 1 primary_doc.xml X0708 D LIVE 0001832728 Apertor Pharmaceuticals, Inc. 230 PARK AVENUE SUITE 2800 NEW YORK NY NEW YORK 10169 (857) 352-3657 DELAWARE None None Corporation true 2020 Spiros Liras c/o Apertor Pharmaceuticals, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Seth Harrison c/o Apertor Pharmaceuticals, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Paul Eisenberg c/o Apertor Pharmaceuticals, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Edmund Graziani c/o Apertor Pharmaceuticals, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Robert T. Abraham c/o Apertor Pharmaceuticals, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Pharmaceuticals Decline to Disclose 06b false 2020-11-05 false true false 0 50000000 3000000 47000000 false 1 0 0 0 false Apertor Pharmaceuticals, Inc. /s/ Spiros Liras Spiros Liras President 2020-11-17